Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ebaa Al-Obeidi
Observed names:
E. Al-Obeidi,
Ebaa Alobeidi
Institutions:
University of California Davis Medical Center,
University of California, Davis
Observed institutions:
University of California Davis Medical Center,
UC Davis Comprehensive Cancer Center,
University of California, Davis
ORCID:
0000-0003-1902-614X
Observed ORCID:
0000-0003-1902-614X
OpenAlex ID:
A5049293732
Phase I/II trial of BMS-986,205 and nivolumab as first line therapy in hepatocellular carcinoma
2023
·
Jasmine C. Huynh
, May Cho
, et al.
·
Investigational New Drugs
·
26
PDF
Evolving Precision First-Line Systemic Treatment for Patients with Unresectable Non-Small Cell Lung Cancer
2024
·
Tianhong Li
, Weijie Ma
, et al.
·
Cancers
·
21
PDF
Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung Cancer
2023
·
Ebaa Al-Obeidi
, Jonathan W. Riess
, et al.
·
Hematology/Oncology Clinics of North America
·
14
Durable Responses to Afatinib as First-line Therapy for HER2-mutated Metastatic Non–small-cell Lung Cancer
2019
·
Ebaa Al-Obeidi
, Tianhong Li
, et al.
·
Clinical Lung Cancer
·
7
PDF
Complications in Acute Myeloid Leukemia Inductions Prior to Count Recovery: A Feasibility Study for Outpatient Care at an Academic Center
2020
·
Christina Poh
, Ebaa Alobeidi
, et al.
·
Blood
·
3
[ 68 Ga]Ga-DOTA-5G PET/CT Detects Brain and Bone Metastases in a Patient with Metastatic Pancreatic Cancer
2026
·
Cameron C. Foster
, Tanushree Ganguly
, et al.
·
Journal of Nuclear Medicine
·
1
CNS Antitumor Activity of Amivantamab With Osimertinib in Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer With Acquired Mesenchymal-Epithelial Transition Amplification Resistance Mechanism: A Case Report
2024
·
Ebaa Al-Obeidi
, Karen Kelly
, et al.
·
JCO Precision Oncology
·
1
Current evidence for neoadjuvant therapy in resectable pancreatic cancer
2024
·
Ebaa Al-Obeidi
, Edward J. Kim
·
AME Clinical Trials Review
CNS antitumor activity of amivantamab added to osimertinib in EGFR-mutant non–small cell lung cancer with MET amplification as acquired resistance to osimertinib: a case report
2023
·
Ebaa Al-Obeidi
, Jonathan Riess
, et al.
·
International Journal of Cancer Care and Delivery
PDF
EP06.03-16 Demographic and Genomic Characteristics of Non-Small Cell Lung Cancer Patients with ARID1A Alterations
2023
·
E. Al-Obeidi
, A. Williams
, et al.
·
Journal of Thoracic Oncology
PDF
Small Cell Lung Cancer
2022
·
Ebaa Al-Obeidi
, Karen Kelly
·
Springer Publishing Company eBooks
Show more works
View as search
Works count:
11
Citation count:
73
H-index:
4
I10-index:
3
Year
Topic
Type